版本:
中国

BRIEF-Positive results published in nephrology dialysis transplantation from two China phase 2 trials

March 30 Fibrogen Inc:

* Positive results published in nephrology dialysis transplantation from two China phase 2 trials of roxadustat for treatment of anemia in chronic kidney disease

* Published results from two China phase 2 program continue to show that that roxadustat corrects and maintains hemoglobin levels Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐